Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

导出 LinkOut

翻译打印收藏纠错

作者： Emma,Boehm ^[1] ; Terry,Hung ^[1] ; Tim,Akhurst ^[1] ; Ramin,Alipour ^[1] ; Cherie,Chiang ^[2] ; Rodney J,Hicks ^[3] ; Michael S,Hofman ^[1] ; Aravind S,Ravi Kumar ^[4] ; Nirupa,Sachithanandan ^[2] ; Javad,Saghebi ^[1] ; Michael,Michael ^[5] ; Grace,Kong ^[4]

作者单位： Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. ^[1] Department of Internal Medicine, Endocrinology, Peter MacCallum Cancer Centre, Melbourne, Australia. ^[2] Department of Medicine, St Vincent's Medical School, The University of Melbourne, Melbourne, Australia. ^[3] Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. ^[4] Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.;Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne. ^[5]

关键词 ectopic Cushing’s syndrome neuroendocrine neoplasms peptide receptor radionuclide therapy radionuclide therapy theranostics

DOI 10.1530/EO-24-0013

PMID 39649117

发布时间 2024-12-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Endocrine oncology (Bristol, England)

2024年4卷1期

e240013页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

Endocrine oncology (Bristol, England)

相似文献

Endocrine oncology (Bristol, England)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

Endocrine oncology (Bristol, England)

相似文献

Endocrine oncology (Bristol, England)

相关期刊

检索历史清除